Novavax (NVAX) Looks Good: Stock Moves 11% Higher - Tale of the Tape
Novavax, Inc. ( NVAX ) was a big mover last session with its shares rising 11% on the day. The move came on solid volume with far more shares changing hands than in a normal session. This continues the recent uptrend of the company as the stock has gained roughly 35% in the past one-month time frame.
This clinical-stage vaccine company has seen no estimate revision in the last 30 days. The Zacks Consensus Estimate hasn't been in trend either. Yesterday's rally is encouraging though, so make sure to keep a close watch on this firm in the near future.
Novavax currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.
Investors interested in the biomedical industry may consider AMAG Pharmaceuticals, Inc. ( AMAG ), which sports a Zacks Rank #1 (Strong Buy).